Virtual Webinar
Telehealth and Substance Use Disorder Treatment
Presented by
Lewei (Allison) Lin MD, MS, DFASAM
1.5 CE Hours
Clinical
Intermediate
Telehealth and Substance Use Disorder Treatment
Pricing
References
References
- Girard, R., Foreman, J., Pinnette, E., Bonar, E. E., Fernandez, A., & Lin, L. A. (2023). Telehealth-delivered Psychotherapy for the Treatment of Alcohol Use Disorder: Patient Perspectives in the Age of COVID-19. Journal of Ad
- Perumalswami, P. V., Adams, M. A., Frost, M. C., Holleman, R., Hyungjin Myra Kim, Zhang, L., & Lewei (Allison) Lin. (2024). Telehealth and delivery of alcohol use disorder treatment in the Veterans Health Administration. Alcohol, Clinical & Experimental Research, 48(5), 944–954. https://doi.org/10.1111/acer.15305
- Lin, L. (Allison), Casteel, D., Shigekawa, E., Weyrich, M. S., Roby, D. H., & McMenamin, S. B. (2019). Telemedicine-delivered treatment interventions for substance use disorders: A systematic review. Journal of Substance Abuse Treatment, 101, 38–49. https://doi.org/10.1016/j.jsat.2019.03.007
- Bonar, E. E., Goldstick, J. E., Rostker, M. J., Dailey, S. E., Augustiniak, A. N., Brin, C., Manderachia, D. A., Bourque, C., Girard, R., Sulkowski, L., & Lin, L. A. (2024). Testing a new model of telehealth-delivered treatment for primary care patients with alcohol use disorder: A randomized controlled trial protocol. Contemporary Clinical Trials, 142, 107549–107549. https://doi.org/10.1016/j.cct.2024.107549
- Frost, M. C., Zhang, L., Kim, H. M., & Lin, L. (Allison). (2022). Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic. JAMA Network Open, 5(10), e2236298–e2236298. https://doi.org/10.1001/jamanetworkopen.2022.36298